Recent research has shown that the occurrence of gender disparity in liver cancer associated with sex differences in MyD88-dependent IL-6 production, but the role of this signaling pathway in sex differences of non-alcoholic steatohepatitis (NASH) remains unknown. To investigate the effects of sex hormone-specific intervention on pathology and progression of NASH, and on the inflammatory TLR-MyD88-IL-6 signaling pathway NASH was modeled in C57/BL6 mice by feeding a methionine and choline-deficient (MCD) diet for 4 weeks. Male mice were subjected to sex hormone-related interventions such as orchidectomy, and orchidectomy combined with administration of either testosterone propionate or estradiol benzoate. Next, the degree of non-alcoholic fatty liver disease activity score (NAS), serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and the expression level of MyD88 and IL-6, were compared between these groups. Males developed more serious inflammatory problems and had a higher NAS than the females. Sex-specific intervention in male mice by orchidectomy reduced NAS, ALT, and AST, and the expression level of MyD88 and IL-6. But administration of exogenous androgen had no influence on either NAS or the expression of ALT, AST, MyD88, and IL-6. On the other hand, exogenous estrogen could alleviate the pathological damage caused by NASH, as well as reduce NAS, ALT and AST, and the expression of MyD88 and IL-6. The result show different sex hormone-related interventions affected the severity of NASH, possibly by modulating the level of sex hormones and regulating the TLR-MyD88-IL-6 signaling pathway.
AlwardWLMcMahonBJHallDBHeywardWLFrancisDPBenderTR. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis1985; 151(4): 604–9.
2.
YokoyamaYNimuraYNaginoMBlandKIChaudryIH. Current understanding of gender dimorphism in hepatic pathophysiology. J Surg Res2005; 128(1): 147–56.
3.
FattovichGBrolloLGiustinaGNoventaFPontissoPAlbertiAAlbertiARealdiGRuolA. Natural history and prognostic factors for chronic hepatitis type B. Gut1991; 32(3): 294–8.
4.
YuMWYangYCYangSYChengSWLiawYFLinSMChenCJ. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: A nested case-control study among men. J Natl Cancer Inst2001; 95(7): 559–60.
5.
FurusyoNHayashiJSawayamaYKishiharaYKashiwagiS. Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: A prospective, long-term, follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection. Am J Trop Med Hyg1999; 60(4): 616–22.
6.
KashiwagiSHayashiJIkematsuHNomuraHKusabaTShinguTHayashidaKKajiM. An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan. Am J Epidemiol1983; 118(6): 787–94.
7.
BeckerUDeisASørensenTIGrønbaekMBorch-JohnsenKMüllerCFSchnohrPJensenG. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study. Hepatology1996; 23(5): 1025–9.
8.
AshleyMJOlinJSle RicheWHKornaczewskiASchmidtWRankinJG. Morbidity in alcoholics. Evidence for accelerated development of physical disease in women. Arch Intern Med1977; 137(7): 883–7.
9.
El-SeragHBRudolphKL. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology2007; 132(7): 2557–76.
10.
WelshJAKarpenSVosMB. Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988–1994 to 2007–2010. J Pediatr2013; 162(3): 496–500.
11.
FanJGLiFCaiXBPengYDAoQHGaoY. The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J Gastroenterol Hepatol2007; 22(5): 663–8.
12.
WangZXiaBMaCHuZChenXCaoP. Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China. Postgrad Med J2007; 83(977): 192–5.
13.
HashimotoETokushigeK. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol2011; 46(Suppl 1): 63–9.
14.
YatsujiSHashimotoETobariMTokushigeKShiratoriK. Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis. Hepatol Res2007; 37(12): 1034–43.
15.
KirschRClarksonVShephardEGMaraisDAJafferMAWoodburneVEKirschREHall PdeL. Rodent nutritional model of non-alcoholic steatohepatitis: Species, strain and sex difference studies. J Gastroenterol Hepatol2003; 18(11): 1272–82.
16.
SprussAHenkelJKanuriGBlankDPüschelGPBischoffSCBergheimI. Female mice are more susceptible to nonalcoholic fatty liver disease: Sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response. Mol Med2012; 18: 1346–55.
17.
AnezakiYOhshimaSIshiiHKinoshitaNDohmenTKataokaESatoWlizukaMGotoTSasakiJSasakiTSuzukiAOhnishiHHorieY. Sex difference in the liver of hepatocyte-specific Pten-deficient mice: A model of nonalcoholic steatohepatitis. Hepatol Res2009; 39(6): 609–18.
18.
DaryaniNEDaryaniNEAlavianSMZareAFereshtehnejadSMKeramatiMRPashaeiMRHabibollahiP. Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findings. World J Gastroenterol2010; 16(33): 4169–75.
19.
KamadaYKisoSYoshidaYChataniNKizuTHamanoMTsubakioMTakemuraTEzakiHHayashiNTakeharaT. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. Am J Physiol Gastrointest Liver Physiol2011; 301(6): G1031–43.
20.
KashireddyPRRaoMS. Sex differences in choline-deficient diet-induced steatohepatitis in mice. Exp Biol Med (Maywood)2004; 229(2): 158–62.
21.
TianGXSunYPangCJTanAHGaoYZhangHYYangXBLiZXMoZN. Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men. Obes Rev2012; 13(4): 381–7.
22.
MuYSheRZhangHDongBHuangCLinWLiDLiX. Effects of estrogen and androgen deprivation on the progression of non-alcoholic steatohepatitis (NASH) in male Sprague-Dawley rats. Hepatol Res2009; 39(9): 910–20.
23.
ZhangHLiuYWangLLiZZhangHWuJRahmanNGuoYLiDLiNHuhtaniemiITsangSYGaoGFLiX. Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. J Lipid Res2013; 54(2): 345–57.
24.
NauglerWESakuraiTKimSMaedaSKimKElsharkawyAMKarinM. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science2007; 317(5834): 121–4.
YamaguchiKItohYYokomizoCNishimuraTNiimiTFujiiHOkanoueTYoshikawaT. Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice. Lab Invest2010; 90(8): 1169–78.
27.
YamaguchiKItohYYokomizoCNishimuraTNiimiTUmemuraAOkanoueTYoshikawaT. Blockade of IL-6 signaling exacerbates liver injury and suppresses antiapoptotic gene expression in methionine choline-deficient diet-fed db/db mice. Lab Invest2011; 91(4): 609–18.
28.
RohYSSekiE. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol2013; 28(Suppl 1): 38–42.
29.
FarrellGCvan RooyenDGanLChitturiS. NASH is an inflammatory disorder: Pathogenic, prognostic and therapeutic implications. Gut Liver2012; 6(2): 149–71.
30.
HiratsukaMMatsuuraTWatanabeESatoMSuzukiY. Sex and strain differences in constitutive expression of fatty acid ω-hydroxylase (CYP4A-related proteins) in mice. J Biochem1996; 119(2): 340–5.
31.
KleinerDEBruntEMVan NattaMBehlingCContosMJCummingsOWFerrellLDLiuYCTorbensonMSUnalp-AridaAYehMMcCulloughAJSanyalAJ. Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology2005; 41(6): 1313–21.
32.
TheveEJFengYTaghizadehKCormierKSBellDRFoxJGRogersAB. Sex hormone influence on hepatitis in young male A/JCr mice infected with Helicobacter hepaticus. Infect Immun2008; 76(9): 4071–8.
33.
KaishoTAkiraS. Toll-like receptor function and signaling. J Allergy Clin Immunol2006; 117(5): 979–87.
34.
SuzukiNSuzukiSDuncanGSMillarDGWadaTMirtsosCTakadaHWakehamAItieAItieALiSPenningerJMWescheHOhashiPSMakTWYehWC. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature2002; 416(6882): 750–6.
35.
MotshwenePGMoncrieffeMCGrossmannJGKaoCAyaluruMSandercockAMRobinsonCVLatzEGayNJ. An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem2009; 284(37): 25404–11.
36.
KonnoHYamamotoTYamazakiKGohdaJAkiyamaTSembaKGotoHKatoAYujiriTImaiTKawaguchiYSuBTakeuchiOAkiraSTsunetsugu-YokotaYInoueJ. TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS One2009; 4(5): e5674–e5674.
37.
SatoSSanjoHTakedaKNinomiya-TsujiJYamamotoMKawaiTMatsumotoKTakeuchiOAkiraS. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat Immunol2005; 6(11): 1087–95.
